Heart 1999;81:166-170 ( February )
Middle aortic syndrome treated by stent implantation
a Catheterisation
Laboratory, Children's Memorial Health Institute, Al Dzieci Polskich
20, 04-736 Warsaw-Miedzylesie, Poland, b Department of Paediatric Cardiology,
Guy's Hospital, London SE1, UK
Correspondence to: Dr Brzezinska-Rajszys.
Accepted for publication 6 October 1998
Objectives
To
determine outcome of stent implantation in patients with middle aortic syndrome.
Design
Prospective
study, case series.
Setting
A tertiary
paediatric cardiology centre in a children's hospital.
Patients
Five
patients, aged 4 to 17 years (mean 11.4 years), with upper limb
hypertension due to middle aortic syndrome.
Intervention
Stents
were implanted in the mid/lower thoracic/upper abdominal aorta.
Main outcome
measure
Satisfactory deployment of stents and
blood pressure control.
Results
In all
patients, angiocardiography showed long segment stenosis in the mid or
lower thoracic/upper abdominal aorta. The pressure gradient was between
40 and 90 mm Hg (mean 63.2 mm Hg). Seven Palmaz stents were
implanted. Immediately after implantation, the gradient decreased to
between 0 and 35 mm Hg (mean 13.6 mm Hg). Angiography showed a
satisfactory result with widely patent stents in all. In one patient,
thrombosis of the stent occurred six days after implantation. This was
successfully treated with infusion of alteplase, further balloon
dilatation, and implantation of a second stent overlapping the first,
both dilated to 10 mm diameter. One patient had elective redilatation
of the stent six months after implantation, with further reduction of
the gradient from 35 mm Hg to 10 mm Hg. At the latest follow up
between three and 20 months (mean 12.2 months) after stent
implantation, in four patients blood pressure was better controlled
with antihypertensive drugs. One patient was normotensive without
drugs. Computed tomography showed no aneurysm formation in the region
of the stents.
Conclusions
Stent
implantation is a preferable alternative to surgery in the treatment of
patients with middle aortic syndrome and merits further evaluation.
© 1999 by Heart
This article has been cited by other articles:
-
Zeltser, I., Parness, I. A., Ko, H., Holzman, I. R., Kamenir, S. A.
(2003). Midaortic Syndrome in the Fetus and Premature Newborn: A New Etiology of Nonimmune Hydrops Fetalis and Reversible Fetal Cardiomyopathy. Pediatrics
111: 1437-1442
[Abstract] [Full Text] -
Segers, B., Derluyn, M., Barroy, J.-P., Brunet, A. P.
(2001). Isolated supradiaphragmatic descending thoracic aorta stenosis in a Takayasu's disease: surgical cure. Eur. J. Cardiothorac. Surg.
20: 1243-1245
[Abstract] [Full Text] -
Eliason, J. L., Passman, M. A., Guzman, R. J., Naslund, T. C.
(2001). Durability of Percutaneous Angioplasty and Stent Implantation for the Treatment of Abdominal Aortic Coarctation: A Case Report. VASC ENDOVASCULAR SURG
35: 397-401
[Abstract] -
JAIN, A K, BALI, H K
(1999). Stenting for middle aortic syndrome. Heart
82: 534e-534
[Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
